A rationally designed oligopeptide shows significant conformational changes upon binding to sulphate ions.
Oligopeptides that interact with oxoanions were developed by rational design methods.
Oligopeptides that interact with oxoanions were developed by rational design methods.
Starting from the NMR structure of the binary complex between the N-terminal domain of the unphosphorylated enzyme I (EIN) of the phosphoenolpyruvate:sugar phosphotransferase (PTS) …
A monoclonal antibody, AC7, directed against the RGD-binding site of the GPIIIa subunit of the platelet fibrinogen receptor, interacts with activated platelet.